Overview of rationale for optimization, summary of recent clinical evidence, and country guidance to support transition to new ART regimens.
In November 2017, ICAP conducted a webinar sharing an overview of the rationale for optimization, current clinical trials and evidence, as well as guidance for countries planning to transition to optimal antiretroviral regimens. Access the recording of the webinar here. The attached slide deck is an accessible reference to aid policy-makers and country program managers to understand the landscape and clinical evidence to guide decisions around optimization.
